Ocata Therapeutics Inc (NASDAQ:OCAT)

6.73
Delayed Data
As of May 22
 +0.11 / +1.66%
Today’s Change
4.95
Today|||52-Week Range
12.73
+10.51%
Year-to-Date
No recent news for Ocata Therapeutics Inc.

Today’s Trading

Previous close6.62
Today’s open6.61
Day’s range6.61 - 6.95
Volume277,811
Average volume (3 months)194,148
Market cap$240.0M
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-17.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-29.83%
P/E ratioNM
Price/Sales1,206.25
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGRXAgile Therapeutics I...-0.43-3.81%
MSLIMerus Labs Internati...-0.12-4.88%
CORICorium International...+0.50+3.88%
AKBAAkebia Therapeutics ...-0.01-0.12%
Data as of 4:00pm ET, 05/22/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$157.9K
Annual profit (last year)-$34.7M
Net profit margin-22,010.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paul K. Wotton
Chief Operating &
Financial Officer
Edward H. Myles
Corporate headquarters
Marlborough, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers